Legend Biotech Corporation (LEGN)
NASDAQ: LEGN · Real-Time Price · USD
34.89
+0.19 (0.55%)
At close: Jun 18, 2025, 4:00 PM
35.21
+0.32 (0.92%)
After-hours: Jun 18, 2025, 7:56 PM EDT
Legend Biotech Stock Forecast
Stock Price Forecast
The 12 analysts that cover Legend Biotech stock have a consensus rating of "Strong Buy" and an average price target of $77.09, which forecasts a 120.95% increase in the stock price over the next year. The lowest target is $55 and the highest is $90.
Price Target: $77.09 (+120.95%)
Analyst Consensus: Strong Buy
* Price targets were last updated on May 14, 2025.
Analyst Ratings
The average analyst rating for Legend Biotech stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Jan '25 | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 6 | 6 | 6 | 5 | 5 | 4 |
| Buy | 7 | 7 | 6 | 7 | 7 | 7 |
| Hold | 0 | 0 | 1 | 1 | 1 | 1 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 13 | 13 | 13 | 13 | 13 | 12 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Truist Securities | Truist Securities | Strong Buy Maintains $88 → $71 | Strong Buy | Maintains | $88 → $71 | +103.50% | May 14, 2025 |
| Cantor Fitzgerald | Cantor Fitzgerald | Buy Reiterates $55 | Buy | Reiterates | $55 | +57.64% | May 14, 2025 |
| RBC Capital | RBC Capital | Buy Reiterates $84 | Buy | Reiterates | $84 | +140.76% | Apr 22, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +114.96% | Apr 16, 2025 |
| HC Wainwright & Co. | HC Wainwright & Co. | Strong Buy Reiterates $75 | Strong Buy | Reiterates | $75 | +114.96% | Apr 8, 2025 |
Financial Forecast
Revenue This Year
1.04B
from 627.24M
Increased by 65.49%
Revenue Next Year
1.60B
from 1.04B
Increased by 53.76%
EPS This Year
-0.62
from -0.97
EPS Next Year
0.53
from -0.62
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 1.2B | 1.9B | 2.9B | ||
| Avg | 1.0B | 1.6B | 2.2B | ||
| Low | 906.6M | 1.2B | 1.7B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 94.3% | 86.8% | 79.8% | ||
| Avg | 65.5% | 53.8% | 34.9% | ||
| Low | 44.5% | 15.5% | 9.4% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | -0.28 | 1.40 | 1.07 |
| Avg | -0.62 | 0.53 | 0.96 |
| Low | -1.10 | 0.28 | 0.89 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 |
|---|---|---|---|
| High | - | - | 102.5% |
| Avg | - | - | 83.1% |
| Low | - | - | 69.4% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.